Mid-Year Report

HORIZON GOVERNMENT AFFAIRS for PHRMA

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Opposition to provisions to include importation or follow-on biologics as part of reauthorization of the Prescription Drug User Fee Act (H.R. 2900/S. 1082)

LobbyistCovered position, as disclosed
JOEL WHITE STAFF DIRECTOR, WAYS AND MEANS HEALTH SUBCMT.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1082 (110th), H.R. 2900 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.